190189-67-4 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
TERT-BUTYL [4-(2-AMINOETHYL)PYRIDIN-2-YL]CARBAMATE is used as a chemical intermediate for the synthesis of bioactive molecules, leveraging its structural features to contribute to the development of new pharmaceutical agents. Its presence in the synthesis process can potentially enhance the biological activity and therapeutic efficacy of the resulting compounds.
Used in Chemical Synthesis:
In the Chemical Synthesis Industry, TERT-BUTYL [4-(2-AMINOETHYL)PYRIDIN-2-YL]CARBAMATE is used as a building block for creating a variety of complex organic molecules. Its unique structure allows for versatile synthetic pathways, making it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Medicinal Chemistry:
In the field of Medicinal Chemistry, TERT-BUTYL [4-(2-AMINOETHYL)PYRIDIN-2-YL]CARBAMATE is utilized as a key component in the design and synthesis of novel drug candidates. Its structural attributes may offer opportunities for the development of compounds with improved pharmacokinetic and pharmacodynamic properties, contributing to the advancement of therapeutic interventions for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 190189-67-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,1,8 and 9 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 190189-67:
(8*1)+(7*9)+(6*0)+(5*1)+(4*8)+(3*9)+(2*6)+(1*7)=154
154 % 10 = 4
So 190189-67-4 is a valid CAS Registry Number.
190189-67-4Relevant academic research and scientific papers
AMINOPYRIDINE COMPOUNDS AND METHODS FOR THE PREPARATION AND USE THEREOF
-
Paragraph 0211, (2018/12/02)
The present invention relates generally to therapeutics targeting the bacterium Porphyromonas gingivalis, including its proteases arginine gingipain A/B (Rgp), and their use for the treatment of disorders associated with P. gingivalis infection, including brain disorders such as Alzheimer's disease. In certain embodiments, the invention provides compounds according to Formula I and Formula III, as described herein, and pharmaceutically acceptable salts thereof.
Fibrinogen receptor antagonists
-
, (2008/06/13)
Fibrinogen receptor antagonists having the structure, for example, of STR1 for example STR2
